Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression
Condition(s):Bipolar DisorderLast Updated:June 11, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Bipolar DisorderLast Updated:June 11, 2021Completed
Condition(s):Sleep Problem; Bipolar DisorderLast Updated:March 31, 2022Enrolling by invitation
Condition(s):Bipolar DisorderLast Updated:September 9, 2021Recruiting
Condition(s):Bipolar DisorderLast Updated:May 14, 2019Completed
Condition(s):Bipolar Disorder; Depressive EpisodeLast Updated:December 2, 2021Recruiting
Condition(s):Bipolar DisorderLast Updated:August 6, 2020Completed
Condition(s):Bipolar DisorderLast Updated:January 6, 2023Not yet recruiting
Condition(s):Bipolar DisorderLast Updated:May 4, 2016Completed
Condition(s):Bipolar DisorderLast Updated:November 3, 2022Recruiting
Condition(s):Bipolar DisorderLast Updated:April 1, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.